At R3 Stem Cell, we coordinate regenerative medicine for Milwaukee patients, including stem cell therapy that uses Mesenchymal stem cells (MSCs) from umbilical cord tissue, bone marrow, or fat. Our providers give image-guided injections for joint, tendon, and nerve discomfort. These cellular therapies stay FDA-regulated and investigational, so candidacy varies.
Non-surgical options for knees, backs, hips, and shoulders that took a beating. Serving Milwaukee and the surrounding counties.
Some pain you can work through. Some pain decides your whole week. If your knee locks up climbing the basement stairs, or your shoulder aches every time you reach the top shelf, you already know which kind you have. R3 Stem Cell helps Milwaukee patients look at stem cell therapy, exosome therapy, and PRP injections as options before surgery.
Health care and manufacturing employ more Milwaukee residents than any other sectors, with roughly 46,000 people in health care and social assistance and nearly 41,000 in manufacturing, according to Census Bureau figures. Those are jobs done on your feet. Lifting. Twisting. Twelve-hour shifts on concrete floors.
Add five months of shoveling, salting, and walking on ice, and the joints let you know about it. Most patients who call us have already tried the standard sequence. Rest. Anti-inflammatories. A cortisone shot that bought a couple of months. Therapy that helped until the schedule got busy again.
Then someone mentions joint replacement, and the real cost shows up: weeks away from work, help at home, and a long rehab. Regenerative medicine is worth understanding before you reach that point.
Request Your Free Stem Cell Evaluation
Stem cell therapy puts concentrated cells or cell signals near damaged tissue so your own repair process gets more support. The main cells used for orthopedic work are mesenchymal stem cells, usually shortened to MSCs.
R3 network providers work from several stem cell treatment options depending on your imaging:
These are injections, not operations. Most take under an hour, most use ultrasound guidance, and most patients drive themselves home afterward.
Knees dominate, usually knee arthritis or an old ligament injury that never healed right. Then low back pain and hip arthritis, then shoulders, including rotator cuff tears, then the joints nobody thinks about until they hurt: hands, wrists, elbows, necks, feet, and ankles. Softball and hockey players call about tendonitis and partial tears. Nurses call about backs. Trades workers call about shoulders and knees, usually both.
We also hear from people dealing with nerve pain and numbness in the feet and hands, circulation concerns, thinning hair, skin restoration, and general anti-aging and orthopedic regenerative care.
Some callers have neurologic, autoimmune, respiratory, or cardiac diagnoses and want to know whether cellular therapies apply. The honest answer depends on the specific diagnosis, and for several of those conditions the real evidence still sits inside clinical research, not private clinics. We will say that plainly rather than sell you something.
This is the section we would want a family member to read first.
Human cell and tissue products in the United States are FDA-regulated. Full federal licensure currently applies only to blood-forming products from cord blood used for certain blood disorders. Orthopedic and IV cellular therapies fall outside of that, offered as investigational or minimally manipulated tissue care. If a clinic anywhere in Wisconsin tells you the injection itself carries federal approval, that is a reason to leave.
What you should expect instead: consent paperwork in plain English, donor-screened tissue from an ISO and cGMP-certified lab, documented cell counts and viability for your specific vial, and a physician who will tell you NO when the imaging says no. Our commitment to every therapy patient spells all of that out.
Side effects are usually mild. Soreness, swelling, bruising, and a short pain flare in the first few days are the common ones. Infection and immune reaction are uncommon but possible with any injection.
First, coverage. Commercial plans and workers’ compensation both exclude care classified as experimental or investigational, and that is exactly how orthopedic cellular therapy is currently classified. If a work injury started this, talk to your claims adjuster before you assume anything. Almost nobody gets reimbursed for these procedures.
Second, trials. Milwaukee has serious academic medicine, and research centers here run clinical studies that are searchable on the federal trial registry at ClinicalTrials.gov. If a study fits your situation better than a paid procedure, we would rather point you there. You can also read the published research behind R3 protocols before your visit.
Pricing generally runs $3,500 to $15,000. What moves the number is the cell source, how many areas get treated, and whether your plan adds exosome or PRP follow-up sessions. One knee sits near the bottom. Multi-joint or intravenous protocols sit higher.
Third-party medical financing is available, and every consultation ends with a written quote. Nothing gets added later.
We do NOT publish a single success rate on this page. Outcomes shift too much with joint, age, remaining cartilage, body weight, and how you use it. Verified Milwaukee-specific outcome data does not exist, and we will not invent a number to fill the gap. What your provider can give you is a straight read on your own imaging, along with patient success stories from people who started where you are.
R3 has coordinated regenerative procedures across a national provider network for years. That consistency matters, because tissue sourcing, lab standards, and consent practices stay the same no matter which clinic you walk into. Here is what sets R3 apart from other stem cell clinics if you are comparing your options. Our coordinators pull your records, confirm your closest treatment center and drive time, and set the consult.
Milwaukee is a city of roughly 563,000 people with a median age near 33, based on recent Census Bureau estimates. Younger than most cities, and harder on its joints than most cities. That combination is why we hear so often from people in their thirties and forties who were told to just live with it.
Bring your questions, your imaging report if you have one, and what you actually want to get back to. We will tell you whether stem cell treatment fits, and we will say so if it does not.
Yes. Licensed physicians in Wisconsin may provide cellular therapies under federal FDA rules for human cells and tissues. These products are FDA-regulated but are not approved drugs for orthopedic or systemic use, so they are offered as investigational or minimally manipulated tissue care with written informed consent.
Generally no. Workers’ compensation carriers and commercial health plans both exclude care classified as experimental or investigational, which is how orthopedic cellular therapy is currently categorized. If a work injury prompted your search, confirm coverage with your claims adjuster before scheduling. Most Milwaukee patients pay out of pocket.
Expect $3,500 to $15,000 across the Milwaukee area. Pricing depends on the cell source, the number of joints treated, and whether exosome or PRP follow-up sessions are included. A single knee sits at the lower end. Intravenous and multi-joint protocols cost more.
PRP concentrates platelets from your own blood to deliver growth factors. Stem cell injections use mesenchymal cells from umbilical cord tissue, bone marrow, or fat. PRP costs less and suits earlier-stage injuries. Cell-based options are typically chosen for advanced cartilage wear or repeated treatment failures.
Most patients describe gradual change across four to twelve weeks rather than immediate relief. Mild soreness, swelling, and a brief pain flare in the first few days are expected. Some providers schedule a second injection near eight to twelve weeks. Response varies by joint, age, and activity level.
Brand Ambassador Gallery
Free Webinar with R3 Stem Cell
All You Need to Know About Stem Cell Therapy Presented by CEO David Greene, MD, PhD, MBA!
R3 Stem Cell Master Class
Learn everything you need to know about the ever expanding field of regenerative medicine in this 8 part series that includes over four hours of entertaining content!
R3 Stem Cell International
R3 Stem Cell International includes 80 clinics in 8 countries. These Centers of Excellence treat all types of conditions with safe, effective protocols by expert stem cell physicians.
Free Stem Cell Consultation
R3 Stem Cell offers a no cost consultation to see if you or a loved one is a candidate for regenerative cell therapies including cytokines, growth factors, exosomes, and stem cells.
Provider
Partnership
The R3 Partnership Program offers providers an all-in-one regenerative practice program including marketing, consultations and booked procedures!
Success Stories
*Outcomes will vary between individuals. No claims are being made with regenerative therapies. The FDA considers stem cell therapy experimental. See our THERAPY COMMITMENT HERE.
The USA Stem Cell Leader Offers Procedures In 8 Countries Including
Call to schedule your free consultation at over 80 centers worldwide!
About Us
R3 Stem Cell is a global leader in regenerative medicine, offering advanced stem cell and exosome therapies through Centers of Excellence in over 80+ locations across 8 countries. Our mission is to provide first-rate, customized… regenerative
Quick Links
Resources
Contact Detail
Subscribe Newsletter
CALIFORNIA
FLORIDA
GEORGIA
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
NEBRASKA
NEW JERSEY
NEW YORK
NEW MEXICO
NEVADA
NORTH CAROLINA
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
Disclaimer
Stem cell therapy is considered experimental and is regulated by the U.S. Food and Drug Administration (FDA), but it is not FDA-approved. R3 Stem Cell does not offer stem cell therapy as a cure for any medical condition. No statements made on this site have been evaluated or approved by the FDA. This site does not provide medical advice. All content is for informational purposes only and is not a substitute for professional medical consultation, diagnosis, or treatment. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.
Copyright © 2017-2026 R3 Stem Cell. All Rights Reserved.
